CVE-2026-86351MISP User Homepage Validation Allows Authenticated Open Redirect via Protocol-Relative URL
Updated under an hour ago ()
Does this affect you?
It affects MISP and 1 other product. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
Affected versions of MISP validate the user-configurable homepage by checking only whether the supplied path begins with /. That check is insufficient because protocol-relative URLs such as //attacker.example also begin with / but resolve to an external origin in browsers. The vulnerable homepage value can be stored as a user setting and later used by the post-login routing logic. The commit explicitly identifies //attacker.example as a payload that passed validation and was emitted to the Location header after login. The fix introduces a shared InternalRedirectValidator that rejects URLs containing a host, scheme, userinfo, unsafe leading // or /\, malformed URLs, and control characters. It also revalidates homepage settings on read so legacy or internally written unsafe values cannot bypass the new storage-time validation. Version affected: ≤2.5.45
- CVSS
- 5.1 MEDIUM (v4.0, CNA)CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:N/VI:N/VA:N/SC:N/SI:L/SA:N
- Weakness (CWE)
- CWE-601, CWE-20
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- CIRCL
- NVD analysis
- Analyzed
- Record last updated
- Sep 8, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
MISP MISP misp:misp (from the name) | through 2.5.45 | CNA record |
misp-project misp misp-project:misp | through 2.5.45 | NVD |
References
- https://github.com/MISP/MISP/commit/bd454f65apatch
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.